146 related articles for article (PubMed ID: 37516333)
21. The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.
Aras G; Gültekin SS; Küçük NO
Nucl Med Commun; 2008 Oct; 29(10):880-4. PubMed ID: 18769305
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of efficacy of various methods of thyroglobulin measurements in differentiated thyroid cancer].
Czernik E; Deja R; Gubała E; Kukulska A; Turska M; Dabrowska-Czuba E; Bartnikowa W; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():339-48. PubMed ID: 12182046
[TBL] [Abstract][Full Text] [Related]
23. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
24. Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulin.
Montella L; Caraglia M; Abbruzzese A; Soricelli A; Prete SD; Squame G; Salvatore M
Exp Mol Med; 2004 Jun; 36(3):268-73. PubMed ID: 15272239
[TBL] [Abstract][Full Text] [Related]
25. Serum thyroglobulin in the monitoring of differentiated thyroid cancer.
Evans C; Tennant S; Perros P
Scand J Clin Lab Invest Suppl; 2016; 245():S119-23. PubMed ID: 27542000
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the new Abbott®Alinity assay for the measurement of thyroglobulin antibodies in patients with differentiated thyroid carcinoma.
Garcia Cano AM; Rosillo Coronado M; Alcázar García L; Gómez Lozano A; Carrasco Sayalero A; Rodriguez Torres A
Ann Clin Biochem; 2023 Mar; 60(2):136-141. PubMed ID: 36653316
[TBL] [Abstract][Full Text] [Related]
27. Follow-up of patients with thyroglobulin-antibodies: Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancer.
de Meer SGA; Vorselaars WMCM; Kist JW; Stokkel MPM; de Keizer B; Valk GD; Borel Rinkes IHM; Vriens MR
Endocr Res; 2017 Nov; 42(4):302-310. PubMed ID: 28509618
[TBL] [Abstract][Full Text] [Related]
28. A Novel Thyroglobulin Immunoassay Using the Specimen-Pretreatment Process Improves the Accuracy of Thyroglobulin Measurements in Anti-Thyroglobulin Positive Specimens.
Kitamura Y; Narita S; Kuroda Y; Yagi S; Aoyagi K
J Appl Lab Med; 2021 Nov; 6(6):1463-1475. PubMed ID: 34580727
[TBL] [Abstract][Full Text] [Related]
29. Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer.
Cho YY; Chun S; Lee SY; Chung JH; Park HD; Kim SW
Ann Lab Med; 2016 Sep; 36(5):413-9. PubMed ID: 27374705
[TBL] [Abstract][Full Text] [Related]
30. Analytical and clinical performance of thyroglobulin autoantibody assays in thyroid cancer follow-up.
Katrangi W; Grebe SKG; Algeciras-Schimnich A
Clin Chem Lab Med; 2017 Oct; 55(12):1987-1994. PubMed ID: 28672730
[TBL] [Abstract][Full Text] [Related]
31. Monitoring differentiated thyroid cancer patients with negative serum thyroglobulin. Diagnostic implication of TSH-stimulated antithyroglobulin antibody.
Nam HY; Paeng JC; Chung JK; Kang KW; Cheon GJ; Kim Y; Park DJ; Park YJ; Min HS; Lee DS
Nuklearmedizin; 2014; 53(2):32-8. PubMed ID: 24276613
[TBL] [Abstract][Full Text] [Related]
32. Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma.
Dekker BL; van der Horst-Schrivers ANA; Brouwers AH; Shuford CM; Kema IP; Muller Kobold AC; Links TP
Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36169927
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic use of the rhTSH/thyroglobulin test in differentiated thyroid cancer patients with persistent disease and low thyroglobulin levels.
Pellegriti G; Scollo C; Regalbuto C; Attard M; Marozzi P; Vermiglio F; Violi MA; Cianci M; Vigneri R; Pezzino V; Squatrito S
Clin Endocrinol (Oxf); 2003 May; 58(5):556-61. PubMed ID: 12699436
[TBL] [Abstract][Full Text] [Related]
34. Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal?
Mariotti S; Barbesino G; Caturegli P; Marinó M; Manetti L; Pacini F; Centoni R; Pinchera A
J Clin Endocrinol Metab; 1995 Feb; 80(2):468-72. PubMed ID: 7852506
[TBL] [Abstract][Full Text] [Related]
35. Discordance in thyroglobulin measurements by radioimmunoassay and immunometric assay: a useful means of identifying thyroglobulin assay interference.
Crane MS; Strachan MW; Toft AD; Beckett GJ
Ann Clin Biochem; 2013 Sep; 50(Pt 5):421-32. PubMed ID: 23847033
[TBL] [Abstract][Full Text] [Related]
36. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.
Chao M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):438-47. PubMed ID: 20561773
[TBL] [Abstract][Full Text] [Related]
37. Thyroglobulin immunoassay with a fully automated pretreatment process provides accurate thyroglobulin values in anti-thyroglobulin antibody positive specimens.
Kitamura Y; Narita S; Yagi S; Aoyagi K
Clin Biochem; 2023 Aug; 118():110598. PubMed ID: 37330000
[TBL] [Abstract][Full Text] [Related]
38. Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome.
Trimboli P; Zilioli V; Imperiali M; Giovanella L
Clin Chem Lab Med; 2017 Oct; 55(12):1995-2001. PubMed ID: 28467308
[TBL] [Abstract][Full Text] [Related]
39. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.
Asa S; Aksoy SY; Vatankulu B; Aliyev A; Uslu L; Ozhan M; Sager S; Halac M; Sonmezoglu K
Ann Nucl Med; 2014 Dec; 28(10):970-9. PubMed ID: 25120245
[TBL] [Abstract][Full Text] [Related]
40. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
Stevic I; Dembinski TC; Pathak KA; Leslie WD
Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
